Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2312
Source ID: NCT00473525
Associated Drug: Placebo
Title: 12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Placebo|DRUG: PF-00734200 10 mg QD|DRUG: PF-00734200 20 mg QD|DRUG: PF-00734200 5 mg QD|DRUG: PF-00734200 2 mg QD
Outcome Measures: Primary: HbA1C levels (%), 12 weeks|Evaluation of Dose Response in HbA1c (%), 12 weeks | Secondary: Insulin and Glucose AUC following a mixed meal tolerance test, 12 weeks|Proportion of subjects achieving ADA glycemic goal of Hb A1c <7%, 12 weeks|Incidence of Adverse Events, 12 weeks
Sponsor/Collaborators: Sponsor: Pfizer
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 303
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2007-07
Completion Date: 2008-06
Results First Posted:
Last Update Posted: 2010-06-24
Locations: Pfizer Investigational Site, Birmingham, Alabama, 35209, United States|Pfizer Investigational Site, Gilbert, Arizona, 85296, United States|Pfizer Investigational Site, Phoenix, Arizona, 85013, United States|Pfizer Investigational Site, Phoenix, Arizona, 85016, United States|Pfizer Investigational Site, Jonesboro, Arkansas, 72401, United States|Pfizer Investigational Site, Little Rock, Arkansas, 72205-6217, United States|Pfizer Investigational Site, Carmichael, California, 95608, United States|Pfizer Investigational Site, Chula Vista, California, 91911, United States|Pfizer Investigational Site, Fair Oaks, California, 95628, United States|Pfizer Investigational Site, Los Angeles, California, 90057, United States|Pfizer Investigational Site, National City, California, 91950, United States|Pfizer Investigational Site, Paramount, California, 90273, United States|Pfizer Investigational Site, Roseville, California, 95661, United States|Pfizer Investigational Site, Sacramento, California, 95825, United States|Pfizer Investigational Site, DeFuniak Springs, Florida, 32435, United States|Pfizer Investigational Site, Destin, Florida, 32541, United States|Pfizer Investigational Site, Jacksonville, Florida, 32216, United States|Pfizer Investigational Site, New Port Richey, Florida, 34652, United States|Pfizer Investigational Site, New Port Richey, Florida, 34653, United States|Pfizer Investigational Site, Palm Harbor, Florida, 34684, United States|Pfizer Investigational Site, West Palm Beach, Florida, 33401, United States|Pfizer Investigational Site, Atlanta, Georgia, 30342, United States|Pfizer Investigational Site, Conyers, Georgia, 30094, United States|Pfizer Investigational Site, Chicago, Illinois, 60607, United States|Pfizer Investigational Site, Skokie, Illinois, 60076, United States|Pfizer Investigational Site, Skokie, Illinois, 60077, United States|Pfizer Investigational Site, Wheeling, Illinois, 60090, United States|Pfizer Investigational Site, Lexington, Kentucky, 40503, United States|Pfizer Investigational Site, Lexington, Kentucky, 40504, United States|Pfizer Investigational Site, Brockton, Massachusetts, 02301, United States|Pfizer Investigational Site, Worcester, Massachusetts, 01602, United States|Pfizer Investigational Site, Ann Arbor, Michigan, 48106, United States|Pfizer Investigational Site, Canton, Michigan, 48187, United States|Pfizer Investigational Site, Flint, Michigan, 48532, United States|Pfizer Investigational Site, Biloxi, Mississippi, 39531, United States|Pfizer Investigational Site, Picayune, Mississippi, 39466, United States|Pfizer Investigational Site, St. Louis, Missouri, 63141, United States|Pfizer Investigational Site, Omaha, Nebraska, 68114, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89119, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89128, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89148, United States|Pfizer Investigational Site, Trenton, New Jersey, 08611, United States|Pfizer Investigational Site, Cary, North Carolina, 27518, United States|Pfizer Investigational Site, Raleigh, North Carolina, 27609, United States|Pfizer Investigational Site, Raleigh, North Carolina, 27612, United States|Pfizer Investigational Site, Marion, Ohio, 43302, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, 73103, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, 73119, United States|Pfizer Investigational Site, Carnegie, Pennsylvania, 15106, United States|Pfizer Investigational Site, East Providence, Rhode Island, 02914, United States|Pfizer Investigational Site, Bartlett, Tennessee, 38134, United States|Pfizer Investigational Site, Collierville, Tennessee, 38017, United States|Pfizer Investigational Site, Kingsport, Tennessee, 37660, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Houston, Texas, 77023, United States|Pfizer Investigational Site, Houston, Texas, 77074, United States|Pfizer Investigational Site, Houston, Texas, 77079, United States|Pfizer Investigational Site, Houston, Texas, 77081, United States|Pfizer Investigational Site, Irving, Texas, 75039, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, San Antonio, Texas, 78237, United States|Pfizer Investigational Site, Richmond, Virginia, 23225, United States|Pfizer Investigational Site, Virginia Beach, Virginia, 23455, United States|Pfizer Investigational Site, Milwaukee, Wisconsin, 53209, United States|Pfizer Investigational Site, Bogota, Cundinamarca, 0, Colombia|Pfizer Investigational Site, Bogota, Cundinamarca, Colombia|Pfizer Investigational Site, Floridablanca, Santander, 0, Colombia|Pfizer Investigational Site, Berlin, 10787, Germany|Pfizer Investigational Site, Giengen, 89537, Germany|Pfizer Investigational Site, Hamburg, 21073, Germany|Pfizer Investigational Site, Muenchen, 81241, Germany|Pfizer Investigational Site, Roma, 00161, Italy|Pfizer Investigational Site, Santiago de Compostela, La Coruña, 15706, Spain|Pfizer Investigational Site, Alcala de Henares, Madrid, 28805, Spain|Pfizer Investigational Site, Valencia, 46009, Spain|Pfizer Investigational Site, Valencia, 46014, Spain|Pfizer Investigational Site, Goteborg, 41665, Sweden|Pfizer Investigational Site, Malmo, 21136, Sweden|Pfizer Investigational Site, Stockholm, 111 57, Sweden
URL: https://clinicaltrials.gov/show/NCT00473525

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress